Agilent Technologies Competitors & Alternatives
Agilent Technologies competitors and alternatives include Thermo Fisher Scientific, Danaher Corporation, etc.…
Jump
-
Stock Price
-
Market Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax Rate (%)
-
Net Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net Income Margin (%)
-
EBITDA
-
Free Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
A
TMO
DHR
Headquarter
Santa Clara
,CA
US
Waltham
,MA
US
Washington
,DC
US
CEO
Mr. Padraig McDonnell
Mr. Marc N. Casper
Mr. Rainer M. Blair
Industry
Medical - Diagnostics & Research
Medical - Diagnostics & Research
Medical - Diagnostics & Research
Stock Price
Stock Price
Market Cap
$29.22 B
$161.38 B
$133.67 B
Employees
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Employees
- 18.10 K
- 18.10 K
- 17.90 K
- 130.00 K
- 122.00 K
- 125.00 K
- 81.00 K
- 63.00 K
- 63.00 K
Y/Y
6.47%
0%
1.1%
0%
6.15%
2.46%
1.25%
22.22%
0%
Revenue Per Employee
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue Per Employee
- $378.34 K
- $377.51 K
- $363.69 K
- $345.50 K
- $351.29 K
- $343.03 K
- $388.53 K
- $379.21 K
- $378.97 K
Y/Y
1.79%
0.22%
3.66%
14.55%
1.67%
2.35%
5.53%
2.4%
0.06%
Net Income Per Employee
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Per Employee
- $69.28 K
- $68.51 K
- $72.01 K
- $53.46 K
- $49.14 K
- $50.68 K
- $89.00 K
- $75.62 K
- $61.89 K
Y/Y
2.66%
1.12%
5.11%
10.03%
8.08%
3.14%
10.68%
15.03%
18.16%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue
- $6.85 B
- $6.83 B
- $6.51 B
- $44.92 B
- $42.86 B
- $42.88 B
- $31.47 B
- $23.89 B
- $23.88 B
Y/Y
8.37%
0.22%
4.73%
14.55%
4.58%
0.05%
6.85%
24.09%
0.06%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Research and Development
- $467.00 M
- $481.00 M
- $479.00 M
- $1.47 B
- $1.34 B
- $1.39 B
- $1.75 B
- $1.50 B
- $1.58 B
Y/Y
5.9%
3%
0.42%
4.62%
9.11%
3.96%
0.17%
13.87%
5.39%
Operating Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income
- $1.62 B
- $1.35 B
- $1.49 B
- $8.39 B
- $6.86 B
- $7.34 B
- $8.69 B
- $5.20 B
- $4.86 B
Y/Y
20.12%
16.56%
10.22%
16.3%
18.28%
6.97%
16.38%
40.12%
6.52%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Tax Rate (%)
- 17.00%
- 7.00%
- 15.00%
- 9.00%
- 5.00%
- 9.00%
- 13.00%
- 16.00%
- 16.00%
Y/Y
50.68%
55.54%
106.36%
28.47%
49.72%
107.1%
20.66%
24.96%
1.47%
Net Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income
- $1.25 B
- $1.24 B
- $1.29 B
- $6.95 B
- $6.00 B
- $6.34 B
- $7.21 B
- $4.76 B
- $3.90 B
Y/Y
3.64%
1.12%
3.95%
10.03%
13.74%
5.67%
12.06%
33.92%
18.16%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Assets
- $10.53 B
- $10.76 B
- $11.85 B
- $97.15 B
- $98.73 B
- $97.32 B
- $84.35 B
- $84.49 B
- $77.54 B
Y/Y
1.62%
2.19%
10.06%
2.14%
1.62%
1.42%
1.4%
0.16%
8.22%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Liabilities
- $5.23 B
- $4.92 B
- $5.95 B
- $53.01 B
- $51.88 B
- $47.65 B
- $34.26 B
- $31.00 B
- $27.99 B
Y/Y
1.67%
5.91%
20.94%
2.11%
2.12%
8.16%
9.86%
9.52%
9.7%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Capital Expenditures (Capex)
- -$291.00 M
- -$298.00 M
- -$378.00 M
- -$2.24 B
- -$1.48 B
- -$1.40 B
- -$1.15 B
- -$1.38 B
- -$1.39 B
Y/Y
53.97%
2.41%
26.85%
11.1%
34.06%
5.34%
10.97%
20.05%
0.65%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income Margin (%)
- 23.63%
- 19.76%
- 22.86%
- 18.69%
- 16.00%
- 17.11%
- 27.61%
- 21.77%
- 20.37%
Y/Y
10.83%
16.38%
15.69%
26.91%
14.39%
6.94%
8.92%
21.15%
6.43%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Margin (%)
- 18.31%
- 18.15%
- 19.80%
- 15.47%
- 13.99%
- 14.77%
- 22.91%
- 19.94%
- 16.33%
Y/Y
4.39%
0.87%
9.09%
21.47%
9.57%
5.58%
4.9%
12.96%
18.1%
EBITDA
2021 | 1725000000.00 |
---|---|
2022 | 1994000000.00 |
2023 | 1703000000.00 |
2024 | 1488000000.00 |
2021 | 12964000000.00 |
---|---|
2022 | 11941000000.00 |
2023 | 11079000000.00 |
2024 | 11535000000.00 |
2021 | 10007000000.00 |
---|---|
2022 | 9712000000.00 |
2023 | 7499000000.00 |
2024 | 4863000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
EBITDA
- $1.99 B
- $1.70 B
- $1.49 B
- $11.94 B
- $11.08 B
- $11.54 B
- $9.71 B
- $7.50 B
- $4.86 B
Y/Y
15.59%
14.59%
12.62%
7.89%
7.22%
4.12%
2.95%
22.79%
35.15%
Free Cash Flow (FCF)
2021 | 1296000000.00 |
---|---|
2022 | 1021000000.00 |
2023 | 1474000000.00 |
2024 | 1373000000.00 |
2021 | 7020000000.00 |
---|---|
2022 | 6911000000.00 |
2023 | 6927000000.00 |
2024 | 7267000000.00 |
2021 | 7064000000.00 |
---|---|
2022 | 7367000000.00 |
2023 | 5781000000.00 |
2024 | 5296000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Free Cash Flow (FCF)
- $1.02 B
- $1.47 B
- $1.37 B
- $6.91 B
- $6.93 B
- $7.27 B
- $7.37 B
- $5.78 B
- $5.30 B
Y/Y
21.22%
44.37%
6.85%
1.55%
0.23%
4.91%
4.29%
21.53%
8.39%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Equity (ROE)
- 23.64%
- 21.21%
- 21.85%
- 15.80%
- 12.83%
- 12.78%
- 14.39%
- 8.91%
- 7.87%
Y/Y
5.3%
10.28%
3.02%
16.58%
18.8%
0.39%
1.05%
38.08%
11.67%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Assets (ROA)
- 11.91%
- 11.52%
- 10.88%
- 7.15%
- 6.07%
- 6.51%
- 8.55%
- 5.64%
- 5.03%
Y/Y
5.4%
3.27%
5.56%
11.95%
15.1%
7.25%
10.61%
34.04%
10.82%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Debt to Equity
- 52.20%
- 46.79%
- 57.48%
- 78.42%
- 74.71%
- 63.12%
- 39.29%
- 36.53%
- 32.31%
Y/Y
3.08%
10.36%
22.85%
8.26%
4.73%
15.51%
19.98%
7.02%
11.55%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value
- $43.08 B
- $31.54 B
- $39.85 B
- $241.83 B
- $231.72 B
- $225.99 B
- $184.28 B
- $184.05 B
- $183.12 B
Y/Y
12.06%
26.8%
26.37%
17.54%
4.18%
2.47%
19.17%
0.12%
0.51%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to Revenue
- 6.29
- 4.62
- 6.12
- 5.38
- 5.41
- 5.27
- 5.86
- 7.70
- 7.67
Y/Y
18.85%
26.64%
32.64%
28.01%
0.42%
2.52%
24.36%
31.57%
0.45%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to EBITDA
- 21.61
- 18.52
- 26.78
- 20.25
- 20.92
- 19.59
- 18.97
- 24.54
- 37.66
Y/Y
23.92%
14.29%
44.63%
10.48%
3.28%
6.33%
16.72%
29.35%
53.42%